Atlas Trials

Study Assessing Cognition in Relapsing Remitting Multiple Sclerosis (RRMS) Patients Treated With BG00012

Clinical trial NCT02579681 · COMPLETED

Trial details

NCT number
NCT02579681
Sponsor
Biogen
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Multiple Sclerosis, Relapsing-Remitting
Start date
2014-04-30
Primary completion
2016-12-21
Enrollment
221

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.